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Highlights 
 The adoption of ASPs in Saudi hospitals remains low despite establishing a national 
implementation strategy 
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 The lack of enforcement of policies and guidelines is a main contributor to inappropriate 
antimicrobial prescribing 
 Barriers to ASPs adoption in Saudi hospitals are mainly organisational 
 Physicians fears and concerns inhibit their adoption of antimicrobial stewardship practices 
 
Abstract 
Objective: this study aims to explore antimicrobial stewardship programmes (ASPs) team 
members’ perspectives regarding the factors influencing the adoption and implementation of 
these programmes in Saudi hospitals. 
Methods: A qualitative study based on face-to-face semi-structured interviews with 
healthcare professionals involved in Antimicrobial Stewardship Programmes and activities 
across three Ministry of Health (MOH) hospitals in Saudi Arabia (n=18). Interviews were also 
conducted with two representatives of a general directorate of health affairs in a Saudi region 
and two representatives of the Saudi MOH (n=4) between January and February 2017. 
Results: Despite the existence of a national strategy to implement ASPs in Saudi MOH 
hospitals, their adoption and implementation remain low. Hospitals have their own 
antimicrobial stewardship policies but adherence to these is poor. ASP team members 
highlight that the lack of enforcement of policies and guidelines from MOH and hospital 
administration is a significant barrier to ASPs adoption and implementation. Other barriers 
include disintegration of teams, poor communication, lack of recruitment/ shortage of ASP 
team members, lack of education and training, and lack of health information technology (IT). 
Physicians’ fears and concerns in relation to liability are also a barrier to their adoption of 
ASPs. 
Conclusion: This is the first qualitative study exploring barriers to ASPs adoption and 
implementation in Saudi hospitals from the perspectives of ASP team members. Formal 
endorsement of ASPs from MOH, and hospitals’ enforcement of policies and provision of 
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human and health IT resources would improve the adoption and implementation of ASPs in 
Saudi hospitals. 
 
Keywords: Antimicrobial Stewardship Programmes; Saudi Arabia ; Hospitals; Adoption; 
Barriers 
 
1. Introduction 
The high prevalence of Antimicrobial Resistance (AMR) and the emergence of rare and multi-
drug resistant strains are major public health threats in Saudi Arabia and other Arab Gulf 
countries, where one of the largest expatriate populations resides, and more than 10 million 
people travel annually for pilgrimage and Umrah [1,2]. A recent review by Zowawi highlights 
the worrying reports of extended spectrum beta-lactamase (ESBL) producing isolates among 
Escherichia coli and Klebsiella pneumoniae and the widespread of Carbapenem resistant 
Acinetobacter baumannii [3]. With Saudi hospitals reporting soaring AMR rates, widespread 
misuse of antimicrobials and fears of resistance to last resort antibiotics [3,4], interventions 
are urgently needed to curb inappropriate antimicrobials use and resistance rates. 
Implementing Antimicrobial Stewardship Programmes (ASPs) in Saudi hospitals has been 
recommended to optimise the use of antimicrobials and reduce AMR rates [4,5]. The 
potential of these interventions has been recognised by the Saudi  Ministry of Health (MOH) 
through the introduction of a national antimicrobial stewardship plan as part of the Arab Gulf 
regional strategy to reduce the threat of AMR [6].  
 
At a hospital level, evidence suggest the implementation of ASPs in some Saudi tertiary 
hospitals [7–9], and these ASPs are mainly led by Infectious Diseases (ID) consultants, with 
AC
CE
PT
ED
 M
AN
US
CR
IPT
4 
 
limited input from microbiologists and hospital pharmacists [7,8]. However, due to the 
shortage of ID consultants and microbiologists [2], these antimicrobial stewardship initiatives 
face sustainability challenges in tertiary care, and are less likely to be implemented in 
secondary care where adoption of ASPs remains low [10]. Collaborations and the formation 
of Antimicrobial Stewardship Programme (ASP) teams, including microbiologists, hospital 
pharmacists, physicians, nurses, and infection control practitioners could increase hospitals 
capacity to adopt ASPs and improve their implementation [11]. Although various studies 
explored ASP team members’ perspectives on programme adoption and implementation in 
healthcare systems where members’ roles are well developed, data from healthcare systems 
such as Saudi Arabia, where ASP teams are novice remains scarce. Understanding the 
experiences and perspectives of physicians, pharmacists, microbiologists, infection control 
practitioners, hospital managers, nurses and MOH personnel of ASPs adoption could enhance 
the adoption of ASPs in Saudi hospitals. Therefore, this study aims to explore the current ASPs 
perspectives and experiences in Saudi MOH hospitals to identify the factors influencing their 
adoption through a qualitative study.  
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2. Methods 
A sequential mixed-methods project, using both qualitative and quantitative methods was 
conducted; the results of the qualitative aspect of the project are presented here. This was 
the first part of the project, and it involved semi-structured face-to-face interviews with 
healthcare professionals from three randomly selected MOH hospitals: A local 50-beds 
hospital, a regional 180 beds hospital, and a central 380 beds hospital. All hospitals are located 
in a Saudi region (South of Saudi Arabia) or its outskirts. In each setting, ASP team members 
were identified and contacted. Representatives from the general directorate of health affairs 
in the region (Infection Control Department and Pharmaceutical Care Department) and the 
Saudi MOH also participated in this study.  
 
In January and February of 2017, one of the authors conducted the interviews, using a semi-
structured interview guide. This was developed based on a review of the literature and was 
validated by a committee of three ASP pharmacists and two ID consultants. It was then piloted 
in a convenience sample of 16 participants from three MOH hospitals. The guide comprises 
of open-ended questions to explore the experience and perspectives of physicians, hospital 
pharmacists, microbiologists, infection control practitioners, nurses, hospital managers and 
MOH representatives, in relation to the adoption and implementation of ASPs in Saudi MOH 
hospitals, and the barriers influencing ASPs implementation. Further probing questions may 
have been asked based on the participant responses. The identified factors influencing ASPs 
adoption in Saudi MOH hospitals were further explored in the quantitative aspect of the 
project through a national hospitals survey. 
All interviews were transcribed verbatim, and the transcripts were compared with the original 
tape to review for quality and accuracy. The data was analysed independently by two of the 
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authors and was subjected to various stages of inductive coding for thematic development 
[12]. The coders met regularly to review coding and derive themes. The study was approved 
by the University of Hertfordshire Health and Human Sciences Ethics committee (Protocol 
number: LMS/PGR/UH/02344). Official permissions were obtained from participating 
hospitals, and all participants signed informed consent before taking part in the study. 
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3. Results 
A total of 22 interviews were conducted with: 5 physicians, 4 nurses, 3 hospital pharmacists, 
2 infection control practitioners, 1 infectious disease consultant, 1 microbiologist, and 2 
hospital managers representing the three Saudi MOH hospitals. We also interviewed the head 
of the Infection Control Department and the head of the Pharmaceutical Care Department in 
the General Directorate of Health Affairs in the Saudi region, and 1 consultant clinical 
microbiologist and 1 clinical pharmacist representing the Saudi MOH departments of 
Infection Control and Pharmaceutical Care. The participants had a median of 9 years of 
practice (ranging from 2 to 15 years). Interviews lasted up to 40 minutes. The participating 
hospitals details are summarised in table 1, and the participants details are summarised in 
tables 2 and 3. 
 
Several main themes emerged from the interviews including the current state of ASPs in 
hospitals, and barriers to ASPs implementation in Saudi MOH hospitals; these were further 
divided into subthemes. This study suggests that formulary restriction is the main ASP 
strategy adopted in the Saudi MOH hospitals. Further, the adoption and implementation of 
ASPs are hindered by three sets of barriers: First, socio-political context barriers including the 
lack of adherence to guidelines and legislations. Second, healthcare organisation related 
barriers such as lack of management support, disintegration, poor communication, lack of 
recruitment/ shortage of ASP team members, lack of education and training, and the lack of 
health IT. Third, healthcare professionals’ barriers relating to their fears and concerns. The 
following sections provide a detailed description of the emerging themes which are 
summarised in table 4. 
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3.1 The current state of ASPs in hospitals: Formulary restrictions and adherence to guidelines 
The front-end strategy of formulary restrictions is the main ASP strategy adopted in all three 
hospitals. The hospitals ASPs include an Antimicrobial Prescribing Policy in which 
antimicrobials are classified into three categories: A, B and C. 
 
Category A antimicrobials: Unrestricted availability of these antimicrobials. Examples include 
amoxicillin, metronidazole and nystatin 
Category B antimicrobials: Restricted availability of these antimicrobials and approval of a 
specialist is required before they are dispensed. They are usually prescribed by consultants or 
their designees (specialist or resident) following the consultants guidance. Examples of these 
antimicrobials include azithromycin, gentamicin and rifampicin. 
Category C antimicrobials: Antimicrobials in this category are permitted only for specific 
conditions such as sepsis or serious infections caused by multi-drug resistant microorganisms. 
They are usually prescribed by a consultant, and this requires the completion of a justification 
form. Examples of these antimicrobials include Colistimethate, Meropenem and Micafungin.  
 
In addition to the Antimicrobial Prescribing Policy, the hospitals front-end strategy also 
includes regimens for treatment of common infections. Interestingly, there are no written 
rules for switching from intravenous to oral administration of antimicrobials; it is usually up 
to the treating physician to determine the duration of treatment and route of administration. 
 
 
3.2 Barriers to ASP adoption and implementation in Saudi MOH hospitals 
Lack of adherence to guidelines 
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Despite the formal existence of this ASP strategy in the participating hospitals, interviewees 
stressed that lack of adherence to antimicrobial policies and guidelines is a significant barrier 
to ASPs adoption and implementation in hospitals (T1 Q1-4). The lack of adherence to the ASP 
policies and guidelines is down to three main factors. First, physicians are not always aware 
that such policies exist, as this is not a routine part of their orientation programme (T2 Q1-2). 
Second, the ASP guidelines and policies are not always accessible electronically (T2 Q3), as 
the policies are distributed across the departments (by either the Infection Control 
Department or Pharmacy or both) often in a paper format that only a few staff members have 
direct access to. Third, the poor enforcement and implementation of ASP policies is a 
significant contributing factor to the lack of adherence to this strategy. Participants suggested 
vertical enforcement by MOH and hospital management as a potential approach to improving 
engagement of physicians with the ASP strategy (T2 Q4-5). 
 
Lack of administrative/ management support 
The lack of management awareness of ASPs and strategies has been suggested to hinder the 
successful adoption and implementation of ASPs in hospitals (T3 Q1-2). Further, the 
management team is not convinced of the benefits of ASPs in relation to antimicrobials 
consumption, reducing rates of AMR and improving patient outcomes (T3 Q3). This is critical 
as the lack of top management support and commitment have been identified as significant 
barriers to ASPs adoption and implementation in the Saudi MOH hospitals (T3 Q4-5). Top 
management here can, among other initiatives, increase the visibility of the hospital ASP 
strategy and enforce adherence to its policies. 
Disintegration 
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Healthcare professionals involved in delivering antimicrobial stewardship are working in silos 
(T4 Q 1-3), reflecting a disintegrated structure that hinders effective team working of 
antimicrobial stewardship teams. In addition to teams working in silos, many of the 
interviewed physicians further highlighted that “silo mentality” exists even among themselves 
(T4 Q4-5). Further, there appears to be the need for the pharmacy department and 
pharmacists to coordinate antimicrobial stewardship efforts among physicians and nurses (T4 
Q6).  
 
Poor communication 
Healthcare professionals also identified poor communication among the key antimicrobial 
stewardship players as a barrier to ASPs adoption. Pharmacists in particular appear to be key 
initiators and coordinators of antimicrobial stewardship communication (T5 Q1-3). It is 
unclear whether this communication is a reason for the disintegrated teams, or consequence 
of such disintegration.  
 
Shortage of ASP team members 
The shortage of ASP team members has also been suggested as a significant barrier to ASP 
adoption and implementation in Saudi MOH hospitals. The lack of clinical pharmacists, has 
been particularly blamed for the modest levels of adoption of ASPs in the participating 
hospitals. The participants particularly expressed that clinical pharmacists will be able to 
advise on the appropriate use of antibiotics, and most importantly, follow up on policy 
implementation and enhance prescribing practices (T6 Q1-4). The shortage of ID consultants 
has also been associated with poor adoption and implementation of ASPs strategies as not all 
MOH hospitals manage to recruit ID consultants, and the recruited few are often not retained 
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or inundated with allocated cases from neighbouring hospitals (T6 Q5-6). The lack of 
microbiologists and laboratory equipment can also be a barrier to implementing ASPs (T6 Q7). 
But participants recognised that recruiting specialist staff will not be sufficient as these need 
to work together as a team to adopt and implement ASPs in hospitals (T6 Q8). 
 
Need for education & training 
Education and training have been suggested by the participants as major contributors to 
successful ASPs adoption and implementation. Workshops to raise awareness of AMR, and 
education and training related to antimicrobial policies and guidelines, as well as good 
antimicrobial stewardship need to be part of the adoption and implementation strategy (T7 
Q1-4). Further, physicians highlighted that orientation programmes for new starters and 
locums do not include local antimicrobial policies guidelines, and this has contributed to the 
often inappropriate prescribing of antimicrobials (T7 Q5). The participants, particularly 
nurses, also emphasised that raising awareness of antimicrobial resistance and education on 
appropriate use of antimicrobials should also be targeting patients, in recognition of the 
patient and public contribution to antimicrobial resistance (T7 Q 6). 
 
The lack of health IT  
The lack of health information technologies (IT) in Saudi MOH hospitals has been suggested 
as a significant barrier to ASPs adoption. The absence of electronic prescribing prevents the 
monitoring of antimicrobials prescribing and antimicrobials consumption data capture (T8 
Q1-2). Further, even if health information technology is integrated in hospitals, the lack of a 
specialised electronic antimicrobial approval system hinders the adoption of antimicrobial 
stewardship (T8 Q3). A sophisticated IT system is also needed for efficient communication 
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between the various departments and personnel involved in antimicrobial stewardship (T8 
Q4-5); this may reduce the disintegration of teams and improve their communication. 
 
Physicians’ fears and concerns 
One interesting barrier to ASPs adoption in Saudi MOH hospitals is physicians’ fears and 
concerns. One of the physicians’ main concerns is the considerable liability pressure. 
Physicians are often reluctant to change antimicrobials prescribing or reduce the length of 
treatment as per guidelines fearing that the patient may deteriorate. In which case, the 
physician is resorting to defensive prescribing in fear of legal or administrative proceedings 
(T9 Q1-4). Another concern is that the risks and benefits of antimicrobials prescribing are only 
considered for current patients, and not future patients (T9 Q5). The participants also 
highlighted that influencing physicians’ prescribing of antimicrobials can be a difficult path; 
either due to the poor enforcement of guidelines, the liability pressure on physicians or their 
personal traits and behaviours (T9 Q6-7). 
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4. Discussion 
Despite the introduction of a national ASP strategy in 2014, adoption and implementation in 
Saudi MOH hospitals remains low and slow (The progress of implementation has recently 
been reviewed by Alomi [6]). The national ASP strategy of 2014 has so far been merely 
“academic”, and it has not been accompanied by any enforcement measures. Furthermore, 
the lack of national surveillance for antimicrobial use and resistance rates in Saudi Arabia 
[10,14] decreases motivation to reduce inappropriate antimicrobial use and marginalises the 
issue of resistance.  
 
In addition to the lack of enforcement at central level, the same is happening at hospital level. 
Antimicrobial guidelines and policies exist, but prescribers are either unaware of them, 
cannot easily access them, or they are not required to adhere to them. The lack of knowledge 
of standard treatment guidelines and the poor enforcement efforts foster inappropriate 
antimicrobial use and increase the prevalence of resistance [15]. A qualitative study by 
Algahtani et al. (2017)[17] found that accreditation improved the process and 
implementation of change in the hospitals, and in turn, improved the delivery of healthcare 
services and the quality of care.   
 
The lack of top management support has been identified as a significant barrier to ASPs 
adoption. Hospital managers are responsible for organising healthcare services and ensuring 
ultimate safe practice through their actions, goals and behaviours [18]. In Saudi hospitals, 
managers tend to be mainly reactive rather than pro-active, and their role largely involves 
response to and ensuring compliance with rules and regulations set out by government [19]. 
Like in the case of IT innovation adoption for example, managers who are aware of the 
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seriousness of AMR and previous experience of ASPs are more likely to adopt the 
innovation[20]. Without management support, the adoption, implementation and 
continuation of ASPs can be affected, as shown in previous studies [21,22]. 
 
Sobczak (2002) reviewed integration and disintegration within organisations including 
healthcare. While integration refers to collaboration and co-operation within joint 
programmes and projects, disintegration relates to fragmentation and lack of co-operation 
[23]. The latter has been suggested to hinder quality improvement initiatives in Saudi 
hospitals [24]. Furthermore, the importance of inter-departmental collaboration within 
hospitals has been recognised in response to epidemics affecting Saudi Arabia and other 
countries in the region, including the outbreak of Middle East respiratory syndrome-
coronavirus [25].  
 
The lack of inter-departmental collaboration within Saudi hospitals is related to 
communication which has also been identified as poor, and a significant organisation cultural 
barrier to quality improvement initiatives within Saudi hospitals [24] and others [22,26]. 
Information technology (IT) can potentially improve inter-departmental communication and 
improve patient safety in hospitals [27]. Moreover, the use of sophisticated IT systems that 
includes computerized clinical decision support systems can improve antimicrobial 
prescribing practices and reduce the rates of healthcare-associated Clostridium difficile 
infections [28]. Also, IT systems that support the integration of electronic healthcare records 
(EHRs) can enhance the adoption and implementation of antimicrobial stewardship 
programmes in healthcare settings [29].  
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Interestingly, lack of financial resources to fund IT infrastructure was not identified as a factor 
in the study by Hasnain et al [31], and was unclear in the study by aldosari [30]. The size of 
the hospital, however, significantly affected the adoption of EHRs and sophisticated IT 
infrastructure [30]. In relation to ASPs, tertiary hospitals in Saudi Arabia are more likely to 
have reliable microbiology facilities, and recruit ID physicians and clinical pharmacists, 
probably due to the availability of resources (financial and human). However, the remaining 
Saudi hospitals continue to report understaffing and/ or shortage of ASP teams members; a 
barrier shared with hospitals in several other countries [32]. These teams will be responsible 
for coordinating education and training of healthcare professionals within the hospital. This 
education and training role is a key strategy to tackle the inappropriate antimicrobial 
prescribing behaviours of physicians [33]. This can be done, as part of a hospital wide multi-
faceted approach, through dissemination of educational materials [34], audit and feedback 
on performance [35], and manual and automated reminders [36]. 
 
In the absence of enforcement of antimicrobial guidelines and the lack of support for the 
hospital administration, physicians in Saudi MOH hospitals perceive that they have the sole 
responsibility for the patient’s safety and well-being. For that, physicians resort to prescribing 
broad-spectrum antimicrobials to prevent deterioration and complications. Similar practices 
have been reported in other countries [37]. Leadership from the MOH to enforce 
antimicrobial stewardship guidelines, and their enforcement from the hospital 
administration, are likely to address physcians’ fears and concerns. Prescribers are likely to 
consider the risks and benefits of antimicrobials prescribing for current as well as future 
patients [38].  
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To our knowledge, this is the first qualitative study regarding ASPs adoption in Saudi Arabia, 
and the whole GCC region. However, there are limitations to our study. Although we 
interviewed different healthcare professionals involved in antimicrobial stewardship, our 
sample was composed of staff who are aware of ASPs, and thus, there is a possibility that the 
results that are portrayed do not reflect the views of healthcare professionals who lack 
experience of ASPs. Further, our study was based on a small number of hospitals (n=3), which 
were not geographically representative of all Saudi MOH hospitals. A national survey, which 
forms the quantitative part of this project, involving all MOH hospitals would improve our 
understanding of the state and the factors affecting ASPs adoption at a national level. 
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5. Conclusion 
We identified several barriers to ASPs adoption and implementation in Saudi MOH hospitals 
including factors relating to the socio-political context of hospitals, organisational 
characteristics, and healthcare professionals' barriers. The emphasis on enforcement of 
antimicrobial stewardship guidelines could not be more explicit; ASPs adoption and 
implementation in Saudi hospitals must be formally endorsed by the MOH, and enforced and 
supported by the hospital administration to relieve physicians’ liability pressures and improve 
their antimicrobial stewardship practices. The lack of human and health IT resources to 
support antimicrobial stewardship must be addressed before the benefits of ASPs adoption 
and implementation can be realised. 
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Table 1: Hospital characteristics  
Hospital Local Regional Central 
Bed capacity 
 
50 beds 180 beds 380 beds 
Existence of ASP  ˃ 10 years ˃ 10 years ˃ 10 years 
 
ASP strategies 
 
Formulary restrictions Formulary restrictions Formulary restrictions 
ASP team Infection Control 
practitioner (nurse) 
 
Pharmacist 
Infection Control 
practitioner (nurse) 
 
ID consultant 
Pharmacist 
Microbiologist 
Infection Control 
practitioner (nurse) 
 
ID input 
 
No No Yes 
Microbiology input 
 
No No Yes 
Pharmacy input 
 
No Yes Yes 
Management input No 
 
No No 
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Table 2: Details of ASP team members interviewed 
Hospital Local Regional Central 
ID consultant 
 
  1 
Microbiologist 
 
  1 
Pharmacist 
 
 1 2 
Infection control 
practitioner (nurse) 
 
1  1 
Physician 
 
1 2 2 
Nurse 
 
1 1 2 
CEO/ Medical Director 1 
 
 1 
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Table 3: Details of MOH representatives 
Representative Regional directorate Ministry 
Pharmacist 
 
1 1 
Infection Control Practitioner  
 
1  
Microbiologist 
 
 1 
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
26 
 
Table 4: Barriers to ASPs adoption and implementation in Saudi MOH hospitals 
T1: Lack of 
adherence to 
guidelines  
“No monitoring, no implementation of any guidelines” Q1 
“They (doctors) are not checking the policies” Q2 
“There is guideline and this guideline exists and the strategy of using 
it exists but the implementation is very weak” Q3 
“The lack of strict follow up in the hospital; I mean policy is made but 
it was never followed up” Q4 
T2: Reasons for lack 
of adherence to 
guidelines 
“The guidelines of the hospital are not fully clear to me” Q1 
 “We lack full awareness of these guidelines” Q2 
“The availability of the guidelines, sometimes are not on the 
computer” Q3 
“if it is implemented through the Ministry, sure everybody will 
follow” Q4 
“Because of no control, no check…No one can ask a physician why 
you have used such combinations relating to antibiotics” Q5 
T3: Lack of 
administrative/ 
management support 
 
 “The management of the hospital should be aware of the topic to 
follow it…The hospital director should follow up the programme and 
be aware of it” Q1 
“The administration has no awareness about this” Q2 
“The administration must be convinced with the programme and 
support it” Q3 
 “ …and to have a good supervision and commitment from the top 
management” Q4 
 “The difficulties we might face are getting no support from the 
management” Q5 
T4: Disintegration  “ There is a gap between the medical directorate, the hospital 
administration and the technical administrations” Q1 
 “There should be some combined meetings, some combined 
platform for all physicians, nurses, technicians, pharmacists…” Q2 
 “Nurses are one department, pharmacy another one department, 
the doctors are one department- we need team work from 
everybody” Q3 
 “every doctor works alone” Q4 
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 “Doctors are not discussing with each other” Q5 
“There should be cooperation between staff and pharmacy” Q6 
T5: Poor 
communication  
 
“ There is no communication between the pharmacy and doctors as 
there is with infection control” Q1 
“If there is any memo from pharmacy, especially for the- if this 
medicine is not available or sometimes this medicine is-They are not 
sending anything regarding the antibiotic policy” Q2 
“communication is very difficult” Q3 
T6: Shortage of ASP 
team members 
“We don’t have clinical pharmacists” Q1 
“Members in the (ASP) team are infection control and clinical pharmacy… 
there should be such team in the hospital” Q2 
 “It is supposed that every department has an infection control nurse, and 
clinical pharmacist whose role is to follow up the antibiotic use. This idea 
should be applied in every department, not in only one department” Q3 
“The clinical pharmacist, this is a new job for us, we need to increase the 
number of infectious disease staff… because we only have one doctor for 
the whole hospital” Q4 
“We want an ID consultant, and it is preferred that he remains in his 
position for a long time” Q5 
“The ID’s role is active, but we have only one ID in the hospital. So it is 
difficult to follow up all matters. You need the IDs and you need ID 
pharmacists” Q6 
“We don’t’ have micro-pathologists… peripheral hospitals don’ t have 
culture…there is lack of infrastructure of labs” Q7 
“All of us should be involved. All of us have our own responsibility and 
accountability. It should not be like, only the nurses should do it, also 
doctors, at the same time microbiologists and pharmacy” Q8 
T7: Need for 
education & training 
“You need a lot of training and education before the programme starts 
correctly” Q1 
“There is need for awareness, there should be regular workshops. There 
should be some compulsory workshops that should be arranged and 
everyone should be attending” Q2 
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“We (doctors) need more training and ongoing education programmes 
that are related to antibiotics” Q3 
“You want guideline, monitoring and educated staff to implement the 
(ASP) programme” Q4 
“They (doctors) need to have a good orientation regarding the antibiotic 
policy” Q5 
“Increase the awareness not only within the healthcare team, but also with 
the family and patient” Q6 
T8: Lack of health IT  “Most hospitals don t have e-systems so they can’ t tell us about 
their consumption” Q1 
“60% of hospitals don’t have a good IT system. Out of 20 hospitals, 
60% do not have electronic prescription” Q2 
“The IT system is useless because it dispenses antibiotics without any 
identification….if the IT system is effective so you insist that the 
prescription should not be completed unless the diagnosis, viral, is 
written in. If there is viral infection the programme itself won’t 
respond to give you antibiotics” Q3 
“You need a good system…the IT system that we count on in all the 
communication between departments, between the ID and the 
pharmacy, and we depend on it” Q4 
“we cannot apply antibiotic stewardship if we don t have a good IT 
system and we have good internal communication system between 
the concerned departments: the ID, the pharmacy and the ward” Q5 
T9: Physicians fears 
and concerns 
“ The patient improves so I don’ t want to change this antibiotic, 
because I am afraid that the patient can relapse” Q1 
“I am worried about my patient, if the patient dies, I’m responsible 
for the patient” Q2 
“In the end, doctors here fear to be accused of negligence” Q3 
“I need the motivation and empowerment of the physicians. Because 
they are afraid if they have any problems, they will not be protected 
from top management” Q4 
“They don t consider the future, all they consider is the short term 
effect…I used three antibiotics, so I have covered the patient, and 
this patient will get better” Q5 
“Some doctors refuse to be challenged. He will say I have read about 
the topic and I know what I am doing” Q6 
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“ Because surgeons are not so good with antibiotics” Q7 
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